Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 17.12 USD 1.12% Market Closed
Market Cap: 409m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cartesian Therapeutics Inc
Common Shares Outstanding Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Common Shares Outstanding
$23.9m
CAGR 3-Years
84%
CAGR 5-Years
72%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Common Shares Outstanding
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Shares Outstanding
$1.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Common Shares Outstanding
$537.5m
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Shares Outstanding
$257.7m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Shares Outstanding
$110.1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Cartesian Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
23.9m USD

Based on the financial report for Sep 30, 2024, Cartesian Therapeutics Inc's Common Shares Outstanding amounts to 23.9m USD.

What is Cartesian Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
72%

Over the last year, the Common Shares Outstanding growth was 363%. The average annual Common Shares Outstanding growth rates for Cartesian Therapeutics Inc have been 84% over the past three years , 72% over the past five years .

Back to Top